University of Rhode Island graduate student Taylor Choquette of Warwick recently traveled to Peru with five other students as part of a cytopathology course that examines the challenges of conducting …
This item is available in full to subscribers.
We have recently launched a new and improved website. To continue reading, you will need to either log into your subscriber account, or purchase a new subscription.
If you are a current print subscriber, you can set up a free website account by clicking here.
Otherwise, click here to view your options for subscribing.
Please log in to continue |
|
University of Rhode Island graduate student Taylor Choquette of Warwick recently traveled to Peru with five other students as part of a cytopathology course that examines the challenges of conducting cervical cancer screenings in developing nations.
While in Peru, the students, fresh from passing their board of certification exams, received their first experience providing diagnoses to patients. They examined samples of cervical cells through a microscope and analyzed them for signs of cervical cancer and pre-cancerous lesions. The students, along with Professor Barbara Klitz and Education Coordinator Nadia Saadeh, worked with local health care provider CerviCusco to screen Pap smears collected from women in rural communities.
When they returned to the United States, the students drafted prevention programs for other countries where cervical cancer is the leading cause of cancer death in women.
The University of Rhode Island’s pioneering research extends the university’s influence well beyond its coastal borders, while its unique interdisciplinary courses provide its 16,680 undergraduate and graduate students with global opportunities in an intimate environment. In May 2013, more than 3,200 undergraduate and about 770 graduate degrees were awarded. The university now has about 110,000 alumni worldwide.
Comments
No comments on this item Please log in to comment by clicking here